Drug–Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers-Reference-Cited by-同舟云学术

Drug–Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers

Published:2018-03-07 Issue:6 Volume:67 Page:934-940
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Mogalian Erik¹,Stamm Luisa M¹,Osinusi Anu¹,Brainard Diana M¹,Shen Gong¹,Ling Kah Hiing John¹,Mathias Anita¹

Affiliation:

1. Gilead Sciences, Foster City, California

Funder

Gilead Sciences

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/67/6/934/25632959/ciy201.pdf

Reference19 articles.

1. Epidemiology of hepatitis C virus in HIV-infected patients;Peters;Curr Opin HIV AIDS,2015

2. Epidemiology of viral hepatitis and HIV co-infection;Alter;J Hepatol,2006

3. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study;Martín-Carbonero;Clin Infect Dis,2004

4. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group;Benhamou;Hepatology,1999

5. Liver disease in the HIV-infected individual;Price;Clin Gastroenterol Hepatol,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Efficacy of Sofosbuvir/Velpatasvir in HIV Patients Coinfected with HCV Genotype 3b;Future Virology;2024-01

2. Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and older;Expert Opinion on Drug Metabolism & Toxicology;2023-12-02

3. Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy—Update 2022: Systematic Review;Pharmaceutics;2023-10-18

4. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents;Clinical Pharmacokinetics;2023-09-20

5. Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV: A Systematic Review;Clinical Pharmacokinetics;2023-08-10